Video
Consultation

عربى

Video
Consultation

Book An
Appointment

Accident & Emergency
99616 30000

Help Desk
99616 40000

Robotic
Surgery
Patients Login Portal

Kochi: The Centre of Excellence in Foot and Ankle Surgery and Podiatry at VPS Lakeshore Hospital has become the first centre in India to complete 100 Charcot foot reconstructive surgeries, marking a significant milestone in the treatment of one of the most serious and often overlooked complications of diabetes. The centre achieved the milestone since its establishment in 2022.
The hospital announced the achievement during a press conference held on Wednesday. Addressing the media, Dr Rajesh Simon, Head of Department and Senior Consultant, Foot and Ankle Surgery, said Charcot neuropathic foot remains one of the most frequently misdiagnosed and serious complications affecting people with diabetes.
"Charcot disease affects the bones and joints of the foot, causing them to weaken and fragment, leading to deformity, instability and infection. If not identified and treated appropriately, it can eventually result in amputation. Early diagnosis, a multidisciplinary treatment approach and reconstructive surgery can help restore stability, preserve the limb and improve mobility," he said.
Dr Rajesh Simon, who is also the first Indian Vice-President of the Asian Federation of Foot and Ankle Surgeons (AFFAS), said amputation can have a devastating impact on a person's mobility and is associated with early mortality. "Our focus is on preserving the limb and saving lives. Our full-fledged podiatric laboratory helps us identify high-risk patients and manage complex foot conditions more effectively. We have been receiving referrals from across India and neighbouring countries for the treatment of complex foot and ankle disorders," he said adding that with India witnessing a steady rise in the number of people living with diabetes, the country is also facing a growing burden of unrecognised Charcot foot, a serious but often overlooked complication that can lead to severe deformity and amputation if left untreated.
Studies have shown that 50 to 70 per cent patients undergoing major lower-limb amputation often experience significantly reduced long-term survival, with average survival reported to be around seven years. The mortality associated with major amputation is reported to be among the highest for any medical condition and second only to lung cancer.
Dr Dennis P. Jose, Consultant, Foot and Ankle Surgery, said diabetic patients often fail to recognise injuries because of reduced sensation in their feet. "Minor injuries may go unnoticed and progress into ulcers, infections and eventually amputation. Detailed vascular and neuropathic assessments help identify patients at risk and allow treatment to begin at an early stage, significantly improving outcomes," he said.
Managing Director S.K. Abdulla said the Foot and Ankle Division has helped many patients avoid amputation through timely intervention and specialised care. “This is the only dedicated Centre of Excellence in Foot and Ankle Surgery and Podiatry of its kind in the country, and we receive patients from different parts of the nation as well as neighbouring states for the treatment of complex foot and ankle conditions. Going forward, our focus will be on strengthening early detection, preventive care and rehabilitation services so that more patients can access timely treatment and avoid preventable disability and amputation,” he said.
Group CEO Abhishek Poduri said that wider public awareness is needed to educate people about the importance of early diagnosis and timely treatment in preventing the progression of Charcot foot, reducing the risk of deformity and amputation, and improving patient outcomes. VPS Lakeshore Medical Superintendent Dr. Surta Ram Vishnoi and Corporate Communications Manager Anilkumar T also attended the press conference.
Photo Caption: Dr. Rajesh Simon cuts a cake as part of the celebrations marking VPS Lakeshore Hospital's achievement of completing 100 Charcot Foot Reconstructive Surgeries. Also seen are Managing Director S. K. Abdulla, Group CEO Abhishek Poduri and Medical Superintendent Dr. Surta Ram Vishnoi.